Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 8/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.58 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.54 |
| ▸ | CNR2 | P34972 | 3/20 | 0.54 |
| ▸ | CNR1 | P21554 | 2/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.53 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7963668 | 0.92 | PLA2G2A (0.78) | PLA2G2AKDM4EHSD17B10PTGS2CNR2 | |
| SCHEMBL7961629 | 0.92 | PLA2G2A (0.78) | PLA2G2AKDM4EHSD17B10PTGS2CNR2 | |
| SCHEMBL7962129 | 0.92 | PLA2G2A (0.78) | PLA2G2AKDM4EHSD17B10PTGS2CNR2 | |
| SCHEMBL7962226 | 0.92 | PLA2G2A (0.78) | PLA2G2AKDM4EHSD17B10PTGS2CNR2 | |
| SCHEMBL9371452 | 0.90 | PLA2G2A (0.82) | PLA2G2AKDM4EHSD17B10AKR1C3AKR1C2 | |
| SCHEMBL7952654 | 0.90 | PLA2G2A (0.82) | PLA2G2AKDM4EHSD17B10AKR1C3AKR1C2 | |
| SCHEMBL7964650 | 0.89 | PLA2G2A (1.00) | PLA2G2AKDM4EHSD17B10 | |
| SCHEMBL7963463 | 0.89 | PLA2G2A (1.00) | PLA2G2AKDM4EHSD17B10 | |
| SCHEMBL7961727 | 0.89 | PLA2G2A (1.00) | PLA2G2AKDM4EHSD17B10 | |
| SCHEMBL7953737 | 0.89 | PLA2G2A (1.00) | PLA2G2AKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0620214-B1 | 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors | LILLY CO ELI (US) | 1999-03-03 | — | — | EP | disclosed |
| US-5578634-A | SEPTIC SHOCK TREATMENT | ELI LILLY AND COMPANY (US) | 1996-11-26 | — | — | US | disclosed |
| EP-0620214-A1 | 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors | ELI LILLY AND COMPANY (US) | 1994-10-19 | — | — | EP | disclosed |